Brain metastasis-related microRNAs in patients with advanced breast cancer

Jun Sato, Akihiko Shimomura, Junpei Kawauchi, Juntaro Matsuzaki, Yusuke Yamamoto, Satoko Takizawa, Hiromi Sakamoto, Makoto Ohno, Yoshitaka Narita, Takahiro Ochiya, Kenji Tamura

Research output: Contribution to journalArticle

Abstract

Brain metastasis is a major distant metastasis occurring in patients with advanced breast cancer, and is associated with poor prognosis. MicroRNAs (miRNAs) have a strong influence on various oncological functions and have been reported as potential biomarkers for detecting distant metastasis. Specific biomarkers and unique miRNAs for brain metastasis have yet to be reported. The aim of this study was to identify novel miRNAs in serum, to assist in the diagnosis of brain metastasis in patients with advanced breast cancer. We retrospectively analyzed the medical records of patients with breast cancer and collected clinical data. In addition, we evaluated serum miRNA profiles in patients with breast cancer, with and without brain metastasis, using high-sensitivity microarrays. All patients underwent computed tomography or magnetic resonance imaging brain imaging tests. A total of 51 serum samples from patients with breast cancer and brain metastasis, stored in the National Cancer Center Biobank, were used, and 28 serum samples were obtained from controls without brain metastasis. Two miRNAs, miR-4428 and miR-4480, could significantly distinguish patients with brain metastasis, with area under the receiver operating characteristic curve (AUC) values of 0.779 and 0.781, respectively, while a combination of miR-4428 and progesterone receptor had an AUC value of 0.884. No significant correlations were identified between the expression levels of these two miRNAs in serum and clinical data. We conclude that serum miR-4428 and miR-4480 may be useful as biomarkers for predicting brain metastasis in patients with breast cancer.

Original languageEnglish
Article numbere0221538
JournalPloS one
Volume14
Issue number10
DOIs
Publication statusPublished - 2019 Jan 1

Fingerprint

MicroRNAs
microRNA
metastasis
breast neoplasms
Brain
Breast Neoplasms
Neoplasm Metastasis
brain
Biomarkers
Serum
biomarkers
Area Under Curve
Imaging techniques
Progesterone Receptors
Magnetic resonance
Microarrays
computed tomography
Tomography
magnetic resonance imaging
Neuroimaging

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Sato, J., Shimomura, A., Kawauchi, J., Matsuzaki, J., Yamamoto, Y., Takizawa, S., ... Tamura, K. (2019). Brain metastasis-related microRNAs in patients with advanced breast cancer. PloS one, 14(10), [e0221538]. https://doi.org/10.1371/journal.pone.0221538

Brain metastasis-related microRNAs in patients with advanced breast cancer. / Sato, Jun; Shimomura, Akihiko; Kawauchi, Junpei; Matsuzaki, Juntaro; Yamamoto, Yusuke; Takizawa, Satoko; Sakamoto, Hiromi; Ohno, Makoto; Narita, Yoshitaka; Ochiya, Takahiro; Tamura, Kenji.

In: PloS one, Vol. 14, No. 10, e0221538, 01.01.2019.

Research output: Contribution to journalArticle

Sato, J, Shimomura, A, Kawauchi, J, Matsuzaki, J, Yamamoto, Y, Takizawa, S, Sakamoto, H, Ohno, M, Narita, Y, Ochiya, T & Tamura, K 2019, 'Brain metastasis-related microRNAs in patients with advanced breast cancer', PloS one, vol. 14, no. 10, e0221538. https://doi.org/10.1371/journal.pone.0221538
Sato J, Shimomura A, Kawauchi J, Matsuzaki J, Yamamoto Y, Takizawa S et al. Brain metastasis-related microRNAs in patients with advanced breast cancer. PloS one. 2019 Jan 1;14(10). e0221538. https://doi.org/10.1371/journal.pone.0221538
Sato, Jun ; Shimomura, Akihiko ; Kawauchi, Junpei ; Matsuzaki, Juntaro ; Yamamoto, Yusuke ; Takizawa, Satoko ; Sakamoto, Hiromi ; Ohno, Makoto ; Narita, Yoshitaka ; Ochiya, Takahiro ; Tamura, Kenji. / Brain metastasis-related microRNAs in patients with advanced breast cancer. In: PloS one. 2019 ; Vol. 14, No. 10.
@article{2da81f5d975e4dd082f9ff267c5f5dec,
title = "Brain metastasis-related microRNAs in patients with advanced breast cancer",
abstract = "Brain metastasis is a major distant metastasis occurring in patients with advanced breast cancer, and is associated with poor prognosis. MicroRNAs (miRNAs) have a strong influence on various oncological functions and have been reported as potential biomarkers for detecting distant metastasis. Specific biomarkers and unique miRNAs for brain metastasis have yet to be reported. The aim of this study was to identify novel miRNAs in serum, to assist in the diagnosis of brain metastasis in patients with advanced breast cancer. We retrospectively analyzed the medical records of patients with breast cancer and collected clinical data. In addition, we evaluated serum miRNA profiles in patients with breast cancer, with and without brain metastasis, using high-sensitivity microarrays. All patients underwent computed tomography or magnetic resonance imaging brain imaging tests. A total of 51 serum samples from patients with breast cancer and brain metastasis, stored in the National Cancer Center Biobank, were used, and 28 serum samples were obtained from controls without brain metastasis. Two miRNAs, miR-4428 and miR-4480, could significantly distinguish patients with brain metastasis, with area under the receiver operating characteristic curve (AUC) values of 0.779 and 0.781, respectively, while a combination of miR-4428 and progesterone receptor had an AUC value of 0.884. No significant correlations were identified between the expression levels of these two miRNAs in serum and clinical data. We conclude that serum miR-4428 and miR-4480 may be useful as biomarkers for predicting brain metastasis in patients with breast cancer.",
author = "Jun Sato and Akihiko Shimomura and Junpei Kawauchi and Juntaro Matsuzaki and Yusuke Yamamoto and Satoko Takizawa and Hiromi Sakamoto and Makoto Ohno and Yoshitaka Narita and Takahiro Ochiya and Kenji Tamura",
year = "2019",
month = "1",
day = "1",
doi = "10.1371/journal.pone.0221538",
language = "English",
volume = "14",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Brain metastasis-related microRNAs in patients with advanced breast cancer

AU - Sato, Jun

AU - Shimomura, Akihiko

AU - Kawauchi, Junpei

AU - Matsuzaki, Juntaro

AU - Yamamoto, Yusuke

AU - Takizawa, Satoko

AU - Sakamoto, Hiromi

AU - Ohno, Makoto

AU - Narita, Yoshitaka

AU - Ochiya, Takahiro

AU - Tamura, Kenji

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Brain metastasis is a major distant metastasis occurring in patients with advanced breast cancer, and is associated with poor prognosis. MicroRNAs (miRNAs) have a strong influence on various oncological functions and have been reported as potential biomarkers for detecting distant metastasis. Specific biomarkers and unique miRNAs for brain metastasis have yet to be reported. The aim of this study was to identify novel miRNAs in serum, to assist in the diagnosis of brain metastasis in patients with advanced breast cancer. We retrospectively analyzed the medical records of patients with breast cancer and collected clinical data. In addition, we evaluated serum miRNA profiles in patients with breast cancer, with and without brain metastasis, using high-sensitivity microarrays. All patients underwent computed tomography or magnetic resonance imaging brain imaging tests. A total of 51 serum samples from patients with breast cancer and brain metastasis, stored in the National Cancer Center Biobank, were used, and 28 serum samples were obtained from controls without brain metastasis. Two miRNAs, miR-4428 and miR-4480, could significantly distinguish patients with brain metastasis, with area under the receiver operating characteristic curve (AUC) values of 0.779 and 0.781, respectively, while a combination of miR-4428 and progesterone receptor had an AUC value of 0.884. No significant correlations were identified between the expression levels of these two miRNAs in serum and clinical data. We conclude that serum miR-4428 and miR-4480 may be useful as biomarkers for predicting brain metastasis in patients with breast cancer.

AB - Brain metastasis is a major distant metastasis occurring in patients with advanced breast cancer, and is associated with poor prognosis. MicroRNAs (miRNAs) have a strong influence on various oncological functions and have been reported as potential biomarkers for detecting distant metastasis. Specific biomarkers and unique miRNAs for brain metastasis have yet to be reported. The aim of this study was to identify novel miRNAs in serum, to assist in the diagnosis of brain metastasis in patients with advanced breast cancer. We retrospectively analyzed the medical records of patients with breast cancer and collected clinical data. In addition, we evaluated serum miRNA profiles in patients with breast cancer, with and without brain metastasis, using high-sensitivity microarrays. All patients underwent computed tomography or magnetic resonance imaging brain imaging tests. A total of 51 serum samples from patients with breast cancer and brain metastasis, stored in the National Cancer Center Biobank, were used, and 28 serum samples were obtained from controls without brain metastasis. Two miRNAs, miR-4428 and miR-4480, could significantly distinguish patients with brain metastasis, with area under the receiver operating characteristic curve (AUC) values of 0.779 and 0.781, respectively, while a combination of miR-4428 and progesterone receptor had an AUC value of 0.884. No significant correlations were identified between the expression levels of these two miRNAs in serum and clinical data. We conclude that serum miR-4428 and miR-4480 may be useful as biomarkers for predicting brain metastasis in patients with breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=85073147041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073147041&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0221538

DO - 10.1371/journal.pone.0221538

M3 - Article

C2 - 31603918

AN - SCOPUS:85073147041

VL - 14

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e0221538

ER -